Investment Rating - The report does not explicitly provide an investment rating for the chemical industry Core Insights - The chemical industry is experiencing a slight recovery in profitability, with a year-on-year increase in net profit of 7.54% for the first three quarters of 2025, reversing the declining trend since 2022 [20][23] - The overall revenue for the chemical industry increased by 2.96% year-on-year, reaching 18,663.84 billion yuan [20][23] - The CCPI index averaged 4021.69 points in Q3 2025, reflecting a year-on-year decrease of 11.37% and a quarter-on-quarter decrease of 1.90%, indicating that product prices remain at a low level [20][23] Summary by Sections 1. Revenue and Profit - The chemical industry achieved a revenue of 18,663.84 billion yuan in Q1-Q3 2025, up 2.96% year-on-year, and a net profit of 1,126.98 billion yuan, up 7.54% year-on-year, marking a significant recovery from the previous decline [20][23] - In Q3 2025, the industry recorded a revenue of 6,398.78 billion yuan, which is a slight decrease of 0.08% quarter-on-quarter but an increase of 2.27% year-on-year [23] 2. Profitability - The overall gross margin for the chemical industry in Q1-Q3 2025 was 17.10%, an increase of 0.23 percentage points year-on-year, while the net profit margin was 6.04%, up 0.26 percentage points year-on-year [2] - Specific sub-industries showed significant improvements in profitability, including pesticides (+31,346.91%), fluorochemicals (+124.56%), and adhesives and tapes (+91.69%) [28][30] 3. Cash Flow - The operating cash flow for the chemical industry increased by 20.33% year-on-year in Q1-Q3 2025, indicating strong cash flow management [3] - The net cash ratio has remained above 1 since 2018, reflecting good profitability quality within the industry [3] 4. Investment and R&D - The growth rate of construction projects in the chemical industry has slowed, with a total of 368.08 billion yuan in construction projects as of Q1-Q3 2025, down 16.66% year-on-year [10] - The capital expenditure for the industry in Q3 2025 was 57.919 billion yuan, up 10.81% year-on-year, but the overall trend in capital expenditure as a percentage of revenue is declining [10] 5. Debt Servicing Ability - The asset-liability ratio for the chemical industry was 45.21% as of Q3 2025, showing a slight improvement and indicating manageable debt levels [3][9] 6. Investment Recommendations - The report suggests focusing on four main investment lines: upstream resource assets with strong profitability certainty, supply-side optimization products, low-position leading stocks, and new productivity investment directions during the 14th Five-Year Plan [11][12][14][15]

Core Viewpoint - The expansion of the design capacity of the Xiaogaozhai phosphate mine from 2 million tons per year to 2.9 million tons per year will enhance the company's phosphate production and optimize the upstream and downstream industrial chain, further implementing its integrated phosphate chemical strategy [1] Group 1 - The expansion of the Xiaogaozhai phosphate mine is expected to increase phosphate production and improve the efficiency of phosphate resource utilization [1] - The project will enhance the production capacity of mining and selection to 2.9 million tons per year and 1.2 million tons per year, respectively, while also upgrading to 5G technology to create a smart mine [1] - The completion of the project will meet the growing market demand for phosphate and improve the company's competitiveness and economic benefits [1]

Group 1: Oil and Chemical Industry Outlook - China Galaxy Securities forecasts Brent crude oil prices to range between $60-70 per barrel by 2026, with costs expected to stabilize [1] - The chemical industry is experiencing negative capital expenditure growth since 2024, with supply expected to contract due to the "anti-involution" trend and accelerated elimination of outdated overseas capacity [1] - The "14th Five-Year Plan" draft emphasizes expanding domestic demand, combined with the onset of the US interest rate cut cycle, which is expected to open up demand for chemical products [1] - A dual bottom in supply and demand is anticipated, with strong policy expectations catalyzing a potential cyclical upturn in the chemical industry by 2026, leading to a "Davis Double Play" from valuation recovery to earnings growth [1] Group 2: Specific Chemical Sector Recommendations - PTA industry is operating at low levels, with increasing calls for anti-involution; recommended companies include Hengli Petrochemical, Rongsheng Petrochemical, Xinfon Ming, and Tongkun [1] - Polyester filament capacity is becoming concentrated, with industry self-discipline enhancing cyclical elasticity; recommended companies include Xinfon Ming, Tongkun, and Hengyi Petrochemical [1] - The spandex industry is expected to see increased concentration; recommended companies include Huafeng Chemical and Xinxiang Chemical Fiber [1] - Global demand for pesticides is improving, with bottom-priced varieties likely to rebound; recommended companies include Yangnong Chemical, Runfeng Shares, Jiangshan Shares, Guangxin Shares, and Lier Chemical [1] - Organic silicon capacity expansion is nearing completion, with supply-demand dynamics expected to improve; recommended companies include Hesheng Silicon Industry, Xin'an Shares, and Dongyue Silicon Material [1] - The titanium dioxide industry is facing challenges and opportunities; recommended company is Longbai Group [1] - Refining capacity is being optimized, with a shift from oil to chemicals enhancing effective supply; recommended companies include Sinopec, PetroChina, Rongsheng Petrochemical, and Hengli Petrochemical [1] Group 3: Demand-Supported Chemical Sectors - Strong pricing power from suppliers is expected to sustain high demand for potash fertilizers; recommended companies include Yara International and Dongfang Iron Tower [2] - Phosphate supply and demand remain tight, benefiting resource-based companies; recommended companies include Batian Shares, Yuntianhua, Xingfa Group, and Chuanheng Shares [2] - Strict quota policies are expected to sustain high demand for refrigerants; recommended companies include Juhua Co., Sanmei Co., and Yonghe Co. [2] - Amino acids are expected to maintain their upward trend, with overseas capacity gradually exiting; recommended companies include New Hope Liuhe, Andisu, and Meihua Biological Technology [2] - The chlorinated sugar market is anticipated to see anti-involution, with significant potential for allulose; recommended companies include Jinhui Industrial, Bailong Chuangyuan, and Baolingbao Biology [2] - Vitamins are leading the current round of chemical price increases, entering the second phase; recommended companies include New Hope Liuhe and Zhejiang Medicine [2] - The EU's preliminary anti-dumping ruling is expected to reassess the value of overseas tires; recommended companies include Sailun Tire and Senqilin [2] - The civil explosives industry is developing steadily, with policy guidance likely accelerating industry consolidation; recommended companies include Guangdong Hongda, Yipuli, and Jiangnan Chemical [2] Group 4: New Materials and Technologies - Lightweight humanoid robots may benefit from PEEK as a key solution; recommended companies include Zhongyan Shares, Water Shares, and Guoen Shares [3] - AI is driving global demand for computing power, with electronic-grade PPO expected to grow; recommended companies include Shengquan Group and Dongcai Technology [3] - The domestic substitution of core chip materials, particularly photoresists, is accelerating; recommended companies include Wanrun Shares and Dinglong Shares [3]

Group 1 - The core point of the article is that Batian Co., Ltd. announced a board meeting to discuss the temporary use of idle raised funds to supplement working capital [1] - For the first half of 2025, Batian's revenue composition is as follows: chemical fertilizer manufacturing accounts for 59.65%, phosphate mining accounts for 39.26%, and new energy materials account for 1.09% [1] - As of the report date, Batian's market capitalization is 11.2 billion yuan [1] Group 2 - Dapeng Industrial's strategic placement has significantly benefited its insiders, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a paper profit of 24.92 million yuan for the controlling shareholder and his brother [1]

Core Viewpoint - Despite significant revenue growth driven by high phosphate rock prices, the company faces serious challenges in its green development path due to environmental violations by its subsidiaries [1][4]. Group 1: Environmental Violations - The company's subsidiary, Guizhou Batian New Energy Materials Co., Ltd., was fined 390,000 yuan for operating its 50,000 tons/year phosphoric acid project without completing necessary environmental protection facilities [2]. - The total manager of the subsidiary was also fined 78,000 yuan, resulting in a "double penalty" for the same incident [2]. - This marks the second administrative penalty for the company this year, with previous fines related to significant safety hazards at its phosphate mining project [1][3]. Group 2: Financial Performance - The company anticipates a net profit attributable to shareholders between 450 million yuan and 520 million yuan for the first half of 2025, representing a substantial year-on-year increase of 199.60% to 246.20% [3]. - For the first three quarters of 2025, the company reported revenue of 3.809 billion yuan, a year-on-year increase of 56.50%, and a net profit of 687 million yuan, up 236.13% [3]. - In Q3 2025, the company achieved revenue of 1.266 billion yuan, a year-on-year increase of 43.45%, but a quarter-on-quarter decline of 11.59% [3]. Group 3: ESG Considerations - The company's environmental compliance issues come at a time when investors are increasingly focused on sustainable development and ESG (Environmental, Social, and Governance) principles [4]. - The approaching deadline for rectifying the environmental issues at the phosphoric acid project raises questions about the company's ability to balance growth and environmental responsibility [4].

中天国富证券有限公司 关于深圳市芭田生态工程股份有限公司 公司本次向特定对象发行 A 股股票募集资金扣除发行费用后，投资于以下项目： 单位：万元 | 序号 | 项目名称 | 项目总投资 | 拟投入募集资金 | | --- | --- | --- | --- | | 1 | 硝酸法生产高纯磷酸项目 | 171,776.59 | 35,000.00 | | 2 | 补充流动资金及偿还银行贷款 | 30,000.00 | 15,000.00 | | | 合计 | 201,776.59 | 50,000.00 | （二）募集资金投资项目变更情况 再次使用部分闲置募集资金暂时补充流动资金的核查意见 中天国富证券有限公司（以下简称"中天国富、"保荐人"）作为深圳市芭田生态 工程股份有限公司（以下简称"芭田股份"、"公司"）向特定对象发行股票（以下简称 "本次发行"）的保荐人，根据 《证券发行上市保荐业务管理办法》《上市公司募集 资金监管规则》《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规范 运作》等有关规定，对芭田股份使用部分闲置募集资金暂时补充流动资金的事项进行 了审慎的核查，具体核查情况如下： 一、募集 ...

关于再次使用部分闲置募集资金暂时补充流动资金的公告 深圳市芭田生态工程股份有限公司（以下简称"公司"）于 2025 年 11 月 24 日召开 第九届董事会第三次会议，审议通过了《关于再次使用部分闲置募集资金暂时补充流 动资金的议案》，为提高公司募集资金使用效率，降低财务费用，同意公司在确保不 影响募投项目建设的前提下，使用不超过 24,700.00 万元的闲置募集资金暂时补充流动 资金，该资金仅限使用于与子公司主营业务相关的生产经营，补充流动资金的期限自 董事会审议通过之日起不超过 12 个月，到期前或募投项目需要时及时归还至募集资金 专户。该事项在董事会审批权限范围内，无需提交股东会审议。现将具体事项公告如 下： 证券代码:002170 证券简称:芭田股份 公告编号:25-92 深圳市芭田生态工程股份有限公司 关于再次使用部分闲置募集资金暂时 补充流动资金的公告 一、募集资金的基本情况 经 2023 年 12 月 4 日中国证券监督管理委员会《关于同意深圳市芭田生态工程股 份有限公司向特定对象发行股票注册的批复》（证监许可[2023]2724 号）核准，本公 司向特定对象发行 A 股股票，由中天国富证券有 ...

深圳市芭田生态工程股份有限公司 第九届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 深圳市芭田生态工程股份有限公司（以下简称"公司"）第九届董事会第三次会 议于 2025 年 11 月 24 日（星期一）在公司本部 V1 会议室以现场和通讯方式结合召开。 本次会议的通知已于 2025 年 11 月 17 日以电子邮件、电话、微信等方式送达。本次会 议由董事长黄培钊先生主持，应出席会议的董事 9 名，实际出席会议的董事 9 名，公 司高级管理人员列席了会议。本次会议的召开程序符合《公司法》《证券法》及《公 司章程》等有关法律法规的规定。 深圳市芭田生态工程股份有限公司第九届董事会第三次会议决议公告 二、董事会会议审议情况 证券代码:002170 证券简称:芭田股份 公告编号:25-91 深圳市芭田生态工程股份有限公司董事会 三、备查文件 2025 年 11 月 24 日 （一）第九届董事会第三次会议决议； （二）深交所要求的其他文件。 特此公告。 1 深圳市芭田生态工程股份有限公司第九届董事会第三次会议决议公告 ...

Group 1: Shareholding Changes - Guangli Micro plans to reduce its shareholding by up to 4.4062 million shares, accounting for 2.2359% of the total share capital after excluding repurchased shares [1] - Deepwater Haina intends to reduce its shareholding by up to 1% of the total share capital, which amounts to 177.28 million shares [1] Group 2: Pharmaceutical Developments - Baillie Tianheng's drug application for the first-in-class EGFR×HER3 dual antibody ADC (iza-bren) has been accepted for review by the National Medical Products Administration [2] - Zhongsheng Pharmaceutical has completed the first participant enrollment for the Phase III clinical trial of its innovative drug, Anladiwei granules, for treating influenza in children [2][3] Group 3: Financial Services - China Merchants Bank's wholly-owned subsidiary, China Merchants Jin Investment, has been approved to commence operations with a registered capital of 15 billion yuan [4] - CITIC Bank's wholly-owned subsidiary, Xinyin Jin Investment, has also received approval to start operations with a registered capital of 10 billion yuan [21] Group 4: Corporate Changes - Guiguan Network's chairman, Chen Yu, has resigned due to work changes, and Dai Qingsong has been nominated as the new chairman [5] - Caixin Development's controlling shareholder is undergoing bankruptcy restructuring, with uncertainties regarding the outcome and potential changes in control [6] Group 5: Industry Developments - JinkoSolar has achieved mass production of its new high-efficiency photovoltaic module "Tiger Neo 3.0," with a production efficiency exceeding 24.8% and a power output of 670W, securing 15GW in orders [8] - Ba Tian Co. has received approval for the safety facility design of its 2.9 million tons/year expansion project at the Xiaogaozai phosphate mine [10] Group 6: Strategic Collaborations and Acquisitions - Zhongding Co. has signed a strategic cooperation agreement with Fourier Intelligent Technology to collaborate on humanoid robot components [14] - Jinfu Technology is planning to acquire at least 51% of Guangdong Lanyuan Technology Co., Ltd. through cash payment [15] Group 7: Market Activities - Zhaowei Electric has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue up to 69.0585 million H-shares [16] - Shanneng Electric has received registration approval for its private placement of shares from the China Securities Regulatory Commission [18]

Core Viewpoint - The expansion project of the Xiaogaozhai phosphate mine under Batian Co., Ltd. has made significant progress, increasing its annual production capacity from 2 million tons to 2.9 million tons, which is expected to enhance the company's competitiveness and economic benefits in the phosphate market [1][2][3] Group 1: Project Details - The Xiaogaozhai phosphate mine expansion project has received approval for safety facility design, allowing for an increase in production capacity to 2.9 million tons per year [1][3] - The second phase of the Xiaogaozhai phosphate mine construction project is estimated to cost no more than 150 million yuan, with a construction scale of 900,000 tons per year [2] - The physical selection phase II project at Xiaogaozhai phosphate mine is planned with an investment of no more than 80 million yuan, aiming for a total capacity of 1.2 million tons per year [2] Group 2: Market Context - Phosphate rock is a crucial upstream raw material for various sectors, including water-soluble fertilizers and new energy [2] - The price of domestic 30% grade phosphate rock has remained above 1,000 yuan per ton since the end of 2023, showing a slow upward trend [2] - Analysts believe that the pace of new phosphate rock production capacity will be delayed, maintaining a high level of demand for high-grade phosphate rock in the short to medium term [2]